Cognex (NASDAQ:CGNX) Stock Price Target Lowered at Truist Financial

Cognex (NASDAQ:CGNX – Get Free Report) had its target price lowered by Truist Financial from $74.00 to $57.00 in a report issued on Friday, Benzinga reports. The firm currently has a “hold” rating on the scientific and technical instruments company’s stock. Truist Financial‘s price objective suggests a potential upside of 18.63% from the company’s previous close.

A number of other research firms have also commented on CGNX. HSBC lowered Cognex from a “buy” rating to a “hold” rating and set a $65.00 price target for the company. in a research report on Monday, August 10th. DA Davidson reiterated a “neutral” rating and issued a $65.00 price objective on shares of Cognex in a research note on Wednesday, September 23rd. KeyCorp dropped their target price on shares of Cognex from $80.00 to $65.00 and set an “overweight” rating on the stock in a research report on Friday. Barclays upped their target price on Cognex from $80.00 to $85.00 and gave the company an “overweight” rating in a report on Monday, October 12th. Finally, Zacks Research downgraded Cognex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $73.29.

Read Our Latest Research Report on CGNX

Cognex Stock Performance

Shares of NASDAQ:CGNX traded up $0.56 during midday trading on Friday, reaching $48.05. The company’s stock had a trading volume of 1,793,497 shares, compared to its average volume of 2,127,663. Cognex has a fifty-two week low of $34.60 and a fifty-two week high of $72.88. The firm has a 50 day moving average price of $59.36 and a two-hundred day moving average price of $57.99. The firm has a market capitalization of $8.08 billion, a price-to-earnings ratio of 33.61 and a beta of 1.49.

Cognex (NASDAQ:CGNX – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The scientific and technical instruments company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.01. The firm had revenue of $313.39 million for the quarter, compared to analyst estimates of $313.62 million. Cognex had a net margin of 21.50% and a return on equity of 16.24%. The business’s quarterly revenue was up 13.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.33 earnings per share. As a group, research analysts anticipate that Cognex will post 1.68 earnings per share for the current year.

Institutional Trading of Cognex

Large investors have recently modified their holdings of the business. IFP Advisors Inc increased its holdings in shares of Cognex by 21.6% in the 2nd quarter. IFP Advisors Inc now owns 956 shares of the scientific and technical instruments company’s stock worth $69,000 after buying an additional 170 shares during the last quarter. State of Michigan Retirement System lifted its position in Cognex by 0.5% in the 1st quarter. State of Michigan Retirement System now owns 39,853 shares of the scientific and technical instruments company’s stock worth $1,952,000 after buying an additional 200 shares during the last quarter. Mather Group LLC. lifted its position in Cognex by 81.3% in the 3rd quarter. Mather Group LLC. now owns 446 shares of the scientific and technical instruments company’s stock worth $27,000 after buying an additional 200 shares during the last quarter. SYM FINANCIAL Corp boosted its stake in Cognex by 6.3% in the third quarter. SYM FINANCIAL Corp now owns 3,372 shares of the scientific and technical instruments company’s stock worth $204,000 after buying an additional 201 shares in the last quarter. Finally, Eastern Bank boosted its stake in Cognex by 20.0% in the third quarter. Eastern Bank now owns 1,242 shares of the scientific and technical instruments company’s stock worth $75,000 after buying an additional 207 shares in the last quarter. Institutional investors own 88.12% of the company’s stock.

More Cognex News

Here are the key news stories impacting Cognex this week:

About Cognex

(Get Free Report)

Cognex Corporation develops machine vision and industrial identification technologies that help manufacturers and businesses automate inspection, measurement, guidance, and tracking processes. Its systems use cameras, sensors, software, and artificial intelligence to analyze images and identify products, defects, components, and other objects.

The company’s product portfolio includes vision systems, industrial cameras, vision sensors, barcode readers, optical character recognition tools, three-dimensional vision systems, and machine vision software.

Further Reading

Analyst Recommendations for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.